Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design

BACKGROUND: Adequate reporting of adaptive designs (ADs) maximises their potential benefits in the conduct of clinical trials. Transparent reporting can help address some obstacles and concerns relating to the use of ADs. Currently, there are deficiencies in the reporting of AD trials. To overcome t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimairo, Munyaradzi, Coates, Elizabeth, Pallmann, Philip, Todd, Susan, Julious, Steven A., Jaki, Thomas, Wason, James, Mander, Adrian P., Weir, Christopher J., Koenig, Franz, Walton, Marc K., Biggs, Katie, Nicholl, Jon, Hamasaki, Toshimitsu, Proschan, Michael A., Scott, John A., Ando, Yuki, Hind, Daniel, Altman, Douglas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238302/
https://www.ncbi.nlm.nih.gov/pubmed/30442137
http://dx.doi.org/10.1186/s12916-018-1196-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238302/
https://www.ncbi.nlm.nih.gov/pubmed/30442137
http://dx.doi.org/10.1186/s12916-018-1196-2

Ejemplares similares